Inflammatory Bowel Disease Onset During Secukinumab Treatment: Real Concern or Just an Expression of Dysregulated Immune Response?
Walter FriesAlessandra BelvedereMaria CappelloAmbrogio OrlandoGianluca TrifiròPublished in: Clinical drug investigation (2019)
Careful clinical examination of patients with respect to possible susceptibility to IBD prior to secukinumab therapy is advised.